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Abstract
Background: Exercise testing devices for evaluating cardiopulmonary fitness in patients with severe disability after
stroke are lacking, but we have adapted a robotics-assisted tilt table (RATT) for cardiopulmonary exercise testing
(CPET). Using the RATT in a sample of patients after stroke, this study aimed to investigate test-retest reliability and
repeatability of CPET and to prospectively investigate changes in cardiopulmonary outcomes over a period of four
weeks.
Methods: Stroke patients with all degrees of disability underwent 3 separate CPET sessions: 2 tests at baseline (TB1
and TB2) and 1 test at follow up (TF). TB1 and TB2 were at least 24 h apart. TB2 and TF were 4 weeks apart. A RATT
equipped with force sensors in the thigh cuffs, a work rate estimation algorithm and a real-time visual feedback
system was used to guide the patients’ exercise work rate during CPET. Test-retest reliability and repeatability of
CPET variables were analysed using paired t-tests, the intraclass correlation coefficient (ICC), the coefficient of
variation (CoV), and Bland and Altman limits of agreement. Changes in cardiopulmonary fitness during four weeks
were analysed using paired t-tests.
Results: Seventeen sub-acute and chronic stroke patients (age 62.7 ± 10.4 years [mean ± SD]; 8 females) completed
the test sessions. The median time post stroke was 350 days. There were 4 severely disabled, 1 moderately disabled
and 12 mildly disabled patients. For test-retest, there were no statistically significant differences between TB1 and
TB2 for most CPET variables. Peak oxygen uptake, peak heart rate, peak work rate and oxygen uptake at the
ventilatory anaerobic threshold (VAT) and respiratory compensation point (RCP) showed good to excellent test-
retest reliability (ICC 0.65–0.94). For all CPET variables, CoV was 4.1–14.5 %. The mean difference was close to zero in
most of the CPET variables. There were no significant changes in most cardiopulmonary performance parameters
during the 4-week period (TB2 vs TF).
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Conclusions: These findings provide the first evidence of test-retest reliability and repeatability of the principal
CPET variables using the novel RATT system and testing methodology, and high success rates in identification of
VAT and RCP: good to excellent test-retest reliability and repeatability were found for all submaximal and maximal
CPET variables. Reliability and repeatability of the main CPET parameters in stroke patients on the RATT were
comparable to previous findings in stroke patients using standard exercise testing devices. The RATT has potential
to be used as an alternative exercise testing device in patients who have limitations for use of standard exercise
testing devices.
Keyword: Cardiopulmonary exercise testing, Robotics-assisted tilt table, Stroke, Test-retest reliability, Repeatability
Abbreviations: 6 MWD, Six-minute walk distance; APMHR, Age-predicted maximal heart rate; CoV, Coefficient of
variation; CPET, Cardiopulmonary exercise testing; HR, Heart rate; HRpeak, Peak heart rate; ICC, Intraclass correlation
coefficient; LoA, Limits of agreement; MD, Mean difference; PETCO2, Partial pressure of end-tidal carbon dioxide
tension; PETO2, Partial pressure of end-tidal oxygen tension; RATT, Robotics-assisted tilt table; RCP, Respiratory
compensation point; RERpeak, Peak respiratory exchange ratio; RPE, Rating of perceived exertion; VAT, Ventilatory
anaerobic threshold; V'CO2, Carbon dioxide output; V'E, Minute ventilation; V'E/V'CO2, Ventilatory equivalent of
carbon dioxide; V'E/V'O2, Ventilatory equivalent of oxygen; V'O2, Oxygen uptake; V'O2peak, Peak oxygen uptake;
WRpeak, Peak work rate
Background
Stroke is one of the leading causes of adult disability
worldwide [1, 2]. Stroke affects not only the neurological
system but also influences pulmonary and cardiovascular
health [3, 4]. The effect of stroke on the cardiovascular
system can result from: existing comorbid conditions,
e.g. coronary artery disease; a direct effect of stroke on
impairments in cardiovascular regulation, e.g. stroke pa-
tients frequently have electrocardiographic abnormalities
such as T-wave abnormalities, prolonged QTc interval
and arrhythmia [5]; or, indirectly from weakness, fatigue
or spasticity leading to a sedentary lifestyle and resulting
in a further decline in cardiopulmonary fitness [6].
Cardiopulmonary exercise testing (CPET) is important
to determine a patient’s cardiopulmonary fitness and to
accurately prescribe an individualised exercise programme
[7]. The most commonly used devices, i.e. a treadmill or a
cycle ergometer, cannot be used in all stroke patients –
their use is limited to mildly or moderately impaired
stroke patients [8]. Post stroke impairments such as spas-
ticity, muscle weakness, coordination problem or reduced
joint range of motion may preclude some moderately to
severely impaired stroke patients from performing CPET
on these devices [9, 10]. Recent systematic reviews showed
that suitable methods to measure cardiopulmonary fitness
and to provide appropriate exercise training in stroke pa-
tients with severe disability are still lacking [11, 12]. This
problem needs to be addressed soon because stroke inci-
dence is projected to increase as a result of a higher pro-
portion of older people in the population in the future
[13] and because people who live with disability after
stroke have a longer survival than formerly [14].
In this study, a robotics-assisted tilt table (RATT), which
is used clinically for early neurorehabilitation, was adapted
for CPET. This device was considered to have potential to
be used in severely disabled patients because it has a har-
ness to provide body support and it incorporates thigh cuffs
and foot plates to secure the legs [15]. As the patient is well
supported, the risk of falls or exercise related injuries is
minimised. The RATT was augmented with force sensors,
a work rate calculation algorithm and a visual feedback sys-
tem to facilitate exercise testing and training [16]. A previ-
ous validity and reliability study in healthy individuals
found that peak oxygen uptake and submaximal exercise
thresholds on the RATT were approximately 20 % lower
than for a cycle ergometer [17]. Test-retest reliability of
maximal and submaximal exercise thresholds on the RATT
were comparable to standard exercise devices [17, 18]. Fur-
thermore, a feasibility study in stroke showed that patients
with severe disability could successfully undergo CPET and
exercise training on the RATT [15].
Test-retest reliability of peak and submaximal cardio-
pulmonary exercise parameters, which are normally used
as the main outcomes for exercise intervention studies,
require careful analysis prior to future clinical uptake of
the RATT. Although reliability data in healthy individ-
uals have been established, this form of analysis in stroke
patients with various degrees of disability is still lacking.
The aims of this study were twofold: to investigate test-
retest reliability and repeatability of CPET on the RATT
in stroke patients with all degrees of disability; and to pro-
spectively investigate changes in cardiopulmonary out-
comes in this sample over a period of four weeks.
Methods
Study design and participants
This prospective study was approved by the Ethics Review
Committee of Canton Aargau, Switzerland (Ref. EKNZ
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2014–296). All subjects gave their written informed con-
sent before participating in the study.
Sub-acute and chronic stroke patients were recruited
from Reha Rheinfelden, a rehabilitation centre in the
north-west of Switzerland, from December 2014 to
January 2016. Patient inclusion criteria were: (1) a diagno-
sis of first-ever stroke, either ischaemic or intracerebral
haemorrhagic; (2) ≥ 18 years old; and (3) willing to cooper-
ate in the study and able to attend all testing sessions.
Exclusion criteria were: (1) any contraindications to max-
imal exercise testing according to the American College of
Sports Medicine guidelines [19]; (2) any contraindications
for the RATT based on guidelines from the manufacturer,
e.g. body mass greater than 135 kg, bone instability, or
open skin lesions in the area of the lower limbs and/or
back; (3) severe perceptual or communication problems;
(4) Mini Mental State Examination (MMSE) score ≤ 17
[20]; (5) concurrent neurological diseases, e.g. Parkinson’s
disease; and (6) severe concurrent cardiac or pulmonary
disease. A cardiologist evaluated the cardiac status of all
patients before giving approval for participation.
Study protocol
Patients underwent 3 separate CPET sessions: 2 tests at
baseline (TB1 and TB2) and 1 test at follow up (TF).
TB2 was conducted as soon as possible after TB1, but at
least 24 h later. TB2 and TF were 4 weeks apart. Patients
were instructed to avoid strenuous activity within the
24 h before each test session, not to consume a large
meal 3 h before, and to refrain from caffeine and nico-
tine 12 h prior to testing.
Patients’ characteristics
Gender, age, height, body mass, body mass index (BMI),
type of stroke, time of stroke diagnosis, side of weakness,
comorbidity and current medication were recorded prior
to the first test (Table 1).
Prior to cardiopulmonary exercise testing, functional
measures were assessed using functional ambulation cat-
egory (FAC) [21], the National Institutes of Health
Stroke Scale (NIHSS) [22] and a 6-min walk test (6
MWT) [23]. The 6 MWT was performed indoors along
a straight 50 m walking course. Standardized instruc-
tions were given to the patients according to the guide-
lines. The six-minute walk distance (6MWD) was
recorded.
Cardiopulmonary fitness assessment
Cardiopulmonary exercise testing (CPET) was per-
formed using a robotics-assisted tilt table (RATT; model
Erigo, Hocoma AG, Switzerland; Fig. 1). Each test ses-
sion had the same format. The patient was first trans-
ferred and secured using the body harness, thigh cuffs
and foot plates according to the instruction of the
manufacturer. Then, the patient was tilted upwards to
70 ° and the formal CPET protocol described below was
initiated. During the passive and incremental exercise
phases, the stepping cadence was set at 80 steps/min,
which is the maximal cadence allowed by the device.
The CPET methodology was previously described in
detail elsewhere [15] and it is briefly summarized in the
Table 1 Characteristics and demographic data of subjects
Characteristic (n = 17) Value Range
Age (years) 62.7 ± 10.4 41.0–78.0
Sex, n (%)
Male 9 (52.9 %)
Female 8 (47.1 %)
Height (cm) 169.5 ± 6.6 160.0–183.0
Body mass (kg) 72.3 ± 10.0 57.5–90.0
Body mass index (kg/m2) 25.2 ± 3.2 20.2–33.1
Type of stroke, n (%)
Ischaemic 15 (88.2 %)
Haemorrhagic 2 (11.8 %)
Hemiparetic side, n (%)
Left 7 (41.2 %)
Right 10 (58.8 %)
Stage, n (%)
Sub-acute 6 (35.3 %)
Chronic 11 (64.7 %)
Days post stroke, 485.3 (535.5) 21–1810
median (IQR) 350 (788)
FAC 3.6 ± 2.1 0–5
NIHSS 3.1 ± 3.2 0–11
MMSE score 28.1 ± 2.3 21–30
Modified Rankin Scale
0–2 12 (70.6 %)
3 1 (5.9 %)
4–5 4 (23.5 %)
Comorbidities, n (%)
Hypertension 9 (52.9 %)
Diabetes mellitus 1 (5.9 %)
Dyslipidemia 4 (23.5 %)
None 4 (23.5 %)
Antihypertensive medications, n (%)
β-blocker 2 (11.9 %)
ACE inhibitors 3 (17.6 %)
Calcium channel blockers 3 (17.6 %)
None 9 (52.9 %)
Values are mean ± SD unless otherwise indicated
Abbreviations: n number; SD standard deviation; MMSE Mini Mental State
Examination; IQR interquartile range; FAC functional ambulation category;
ACE angiotensin-converting-enzyme
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following. CPET consisted of the following phases: (1)
a 3-min rest phase, where the patient lay without leg
movement on the RATT; (2) a passive phase, where
the RATT moved the patient’s legs for 5 min and the
measured relative work rate was adjusted to 0 W; (3)
a ramp phase, where the rate of work rate increase
was in the range 1.25 to 4.5 W/min – the work rate
ramp was estimated by patients’ gender, age, level of
weakness and comorbidity, e.g. the ramp rate for a
70 year old woman with severe disability was set to
1.25 W/min – the aim of the individualised ramp rate
was to bring the patient to their limit of functional
capacity within 8–12 min of ramp onset. The individ-
ual ramp increment rates stayed the same for 13 pa-
tients in TB1 and TB2. The ramp rates were adjusted
in four patients in TB2 to enable the patients to
reach their maximal effort in 8–12 min; and (4) a
recovery phase, where the patient remained passive
while the RATT moved their legs for 5 min. The ter-
mination criteria for the ramp phase followed the
American College of Sports Medicine guidelines [19].
Additionally, blood pressure (BP) was used as a ter-
mination criterion: systolic BP > 210 mmHg or dia-
stolic BP > 115 mmHg [24].
Prior to the incremental exercise testing, the re-
searcher showed and explained the Borg CR 10 scale to
the patients. The instructions were as follows: “This
scale aims to measure your feeling of difficulty in breath-
ing and leg fatigue. The range of the scale is from 0 to
10. The number 0 means that you feel no difficulty at
all. The scale progresses to number 10 where you feel
that you have maximal difficulty with breathing/leg
effort.” During the incremental exercise test the patients
rated the Borg CR 10 for dyspnea every 3 min. At the
end of exercise, the patients were asked to rate the Borg
CR 10 for both dyspnea and leg effort.
Metabolic gas exchange was recorded throughout
using a breath-by-breath system (MetaMax 3B, Cortex
Biophysik GmbH, Germany); the data were analysed
using the associated Metasoft software. Prior to each
test, standardized pressure, volume and precision gas
calibration were performed according to the manufac-
turer’s instructions. Heart rate was continuously re-
corded using a chest strap (model T34, Polar Electro Oy,
Finland). Blood pressure was measured by manual
sphygmomanometry every 2 min during the tests.
Outcome measures
The primary outcome measures were:
1. Maximal outcomes:
 Peak oxygen uptake, denoted V'O2peak. This was
determined as the maximum of a 15-breath aver-
age during the ramp phase.
 Peak heart rate, HRpeak: the highest value of HR
during the ramp phase.
 Peak respiratory exchange ratio, RERpeak: the 15-
breath average at the time of V'O2peak.
 Peak work rate, WRpeak. This was calculated as
the highest work rate achieved.
2. Submaximal outcomes:
 Oxygen uptake at the ventilatory anaerobic
threshold VAT (V'O2VAT): the method for
determination of VAT is summarized below.
 Oxygen uptake at the respiratory compensation
point RCP (V'O2RCP), described below.
Fig. 1 Robotics-assisted tilt table (RATT) with visual feedback system. The visual feedback screen shows the target work rate and the subject’s
work rate. The latter was calculated from the forces in the thigh cuffs and the angular velocities. Adapted from Saengsuwan et al., 2015 [18]
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The secondary outcome measures were:
 Rating of perceived exertion (RPE) for dyspnea and
leg effort at the time of peak exercise (Borg CR10)
[25].
 Heart rate at the VAT (HRVAT) and heart rate at the
RCP (HRRCP).
 The value of the ventilatory equivalent of oxygen
(V'E/V'O2) at VAT and ventilatory equivalent of
carbon dioxide (V'E/V'CO2) at RCP, where V'E is
minute ventilation and V'CO2 is carbon dioxide
output, and the slope of V'E-vs-V'CO2 from the
start of the ramp phase to the RCP.
The ventilatory anaerobic threshold (VAT) and the
respiratory compensation point (RCP) were determined
as the averages from two independent raters (JS and LB)
provided that the difference in the V'O2 values of the
corresponding points between two raters was less than
100 mL/min [26]. In the case of any discrepancy, a third
experienced rater (KH) rated the point, and the VAT or
RCP was taken as the average of the 2 closest values.
The methods used to determine the VAT and RCP were
those described by Binder et al. [27] and summarised in
the following.
The VAT was determined using the combination of
these criteria: (1) the point where the V'E/V'O2 reaches
its minimum or starts to increase without an increase in
the V'E/V'CO2; (2) the point at which the partial pres-
sure of end-tidal oxygen tension (PETO2) reaches a mini-
mum or starts to increase without a decline in the
partial pressure of end-tidal carbon dioxide tension
(PETCO2); and, (3) the point of deflection of V'CO2-
versus V'O2 (V-slope method). The first two criteria
were prioritized in the case that the 3 criteria gave differ-
ent results.
The RCP was determined by: (1) the minimal value or
nonlinear rise of V'E/V'CO2; (2) the point that PETCO2
starts to decline; and, (3) the point of deflection of V'E
versus V'CO2. Again, the first two criteria were
prioritized.
Statistical analysis
Continuous variables are presented as mean ± stand-
ard deviation (SD). Categorical variables are presented
as frequencies and percentages. Test-retest reliability
of submaximal parameters on each device was
analysed using an intraclass correlation coefficient
(ICC3,1) [28]. For the interpretation of results, 0.40 ≤
ICC < 0.75 was considered as fair to good reliability
and ICC ≥ 0.75 was considered excellent reliability [29].
The within-subject coefficients of variation (CoV) were
also calculated [30].
Repeatability was analysed using the Bland and Altman
limits of agreement (LoA). Heteroscedasticity was exam-
ined by calculating Pearson’s correlation coefficient (r)
between the absolute difference and the corresponding
means. When r > 0.1 was found, the data were considered
heteroscedastic. The heteroscedastic data were log trans-
formed using base 10 and r was recalculated. If r de-
creased, the data were analysed using log-transformation.
The limits of agreement for heteroscedastic data were
transformed back and displayed in the Bland Altman plots
as a linear function ± bx̄ calculated by the method de-
scribed by Euser et al. [31], where x̄ is the data mean and
b is the slope of the LoA. If the data were homoscedastic,
or the data were heteroscedastic but the log-transformed
data did not reduce the correlation coefficient, the limits
of agreement were reported as the standard mean differ-
ence (MD) ± 1.96 SD of the difference [32].
Two-sided paired t-tests were used to test differences
between TB1 and TB2, as well as between TB2 and TF, if
the difference between the tests was normally distributed
(Shapiro Wilk test). Otherwise, the Wilcoxon-signed rank
test was used. The significance level was set at 0.05. The
analyses were performed using SPSS (Version 20.0, IBM
Corp., Armonk, NY).
Results
General observations
Seventeen patients (8 females, 9 males) aged 62.7 ±
10.4 years (mean ± SD), see Table 1, completed all three
sessions and are included in the data analysis. The me-
dian time post stroke was 350 days. There were 4
severely disabled, 1 moderately disabled and 12 mildly
disabled patients. Three further patients were recruited
but did not complete all measurement sessions because
of, respectively, severe hypertension, new onset atrial
fibrillation, or due to automatic shutdown of the RATT
caused by inappropriate forces. These three patients
were not included in the data analysis
There were no complications or serious adverse
events. The ramp-phase duration was 8 min 53 s ±
2 min 17 s. Of the total of 51 completed exercise test
sessions (17 patients x 3 sessions each), 49 sessions were
terminated at the patient’s own volition (functional cap-
acity reached). The most common reasons for volitional
exercise termination were leg fatigue (45.1 %), generalized
fatigue (17.6 %) and inability to maintain the target work
rate (15.7 %). One session was terminated because blood
pressure reached the upper limit (SBP > 210 mmHg) and
1 session because of pain due to a tension headache.
Overall, the VAT and RCP were identifiable in 49 of 51
tests (96.1 %) and 39 of 51 tests (76.5 %), respectively:
this allowed 16 paired comparisons of V'O2VAT to be
done for TB1 vs TB2 (test-retest) and for TB2 vs TF
(four-week changes); 12 paired comparisons of V'O2RCP
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were able to be done for TB1 vs TB2 and 11 compari-
sons for TB2 vs TF (Fig. 2, Tables 2 and 3). There was
one measurement problem for submaximal heart rate
recording in TB1, so the pairwise comparison for HRVAT
and HRRCP were 1 pair lower than for the submaximal
V'O2 pairs (test-retest).
Test-retest reliability (TB1 vs TB2)
The first and second baseline tests (TB1 and TB2) were
2.1 ± 2.1 days apart. The primary outcomes (V'O2peak,
HRpeak, RERpeak, WRpeak, V'O2VAT and V'O2RCP) showed
good to excellent test-retest reliability with ICCs in the
range of 0.65 to 0.94 (Table 2). Overall, peak exercise
performance parameters showed higher reliability com-
pared to submaximal exercise parameters: V'O2peak had
a better reliability and repeatability shown by a higher
ICC, a lower or equal coefficient of variation and a
smaller mean difference (ICC 0.85 [95 % CI 0.64-0.94],
CoV 11.6 %, MD 25.8 mL/min) compared to V'O2VAT
(ICC 0.67 [95%CI 0.27–0.87], CoV 14.5 %, MD 60.1 mL/
min) and V'O2RCP (ICC 0.65 [95%CI 0.17–0.88], CoV
11.6 %, MD 46.3 mL/min). Most cardiopulmonary exer-
cise parameters were slightly higher in TB2: a statisti-
cally significant difference was found between the tests
only for V'O2VAT (575.4 mL/min in TB1 vs 635.5 mL/
min in TB2, p = 0.045). For the Bland and Altman ana-
lysis, the variables V'O2peak, V'O2VAT and HRVAT as a per-
centage of HR reserve were found to be heteroscedastic
and the limits of agreements were calculated from the
log-transformed data (Table 2, Fig. 3).
Amongst the secondary outcomes, HRVAT, HRRCP, V'E/
V'O2 at VAT, V'E/V'CO2 at RCP and V'E-vs-V'CO2 slope
showed excellent reliability with ICC from 0.76 to 0.87
and CoV less than 8 %. The least reliable parameters as
classified by the highest CoV (28.4 and 29.5 %) were the
patients’ subjective rating of perceived exertion (RPE),
both for leg effort and dyspnea.
Changes in cardiopulmonary fitness after 4 weeks
(TB2 vs TF)
The follow up test (TF) was 30.4 ± 10.2 days after the
second baseline measurement (TB2). No significant
changes were found in V'O2peak, HRpeak, RERpeak,
WRpeak, or V'O2RCP (Table 3), but V'O2VAT showed a sta-
tistically significant decrease (637.4 mL/min in TB2 vs
569.3 mL/min in TF, p = 0.002). Regarding secondary
outcomes, mean RPE for leg effort in TF was lower than
for TB2 but the other variables were comparable
(Table 3).
Discussion
This study had two aims: to investigate test-retest reli-
ability and repeatability of CPET on the RATT in stroke
patients with all degrees of disability; and to prospect-
ively investigate changes in cardiopulmonary outcomes
in this sample over a period of four weeks.
Test-retest reliability
Good to excellent reliability was found in V'O2peak,
HRpeak, RERpeak, WRpeak, V'O2VAT and V'O2RCP. Overall,
there were slightly higher cardiopulmonary performance
parameter values in test 2, but, amongst the formal out-
come measures, only the difference in V'O2VAT reached
statistical significance.
The test-retest reliability of the peak cardiopulmonary
exercise parameters observed here in stroke patients
(V'O2peak ICC of 0.85 and CoV of 11.6 %) was lower
than values seen previously in healthy individuals (ICC
of 0.97 and CoV of 4.1 %) exercising on the RATT [17].
The lower reliability may be explained by the higher
variation in day-to-day levels of motor performance,
levels of fatigue and motivation in stroke patients.
Comparing the test-retest reliability results with other
devices used in stroke patients is difficult as ICCs are
often reported by different ICC methods. Additionally,
test-retest reliability as calculated by other measures
such as CoV are scarce in the stroke literature. Results
from various previous studies found that V'O2peak ob-
tained from a cycle ergometer, a semi-recumbent cycle
ergometer, a treadmill and a robotics-assisted treadmill in
both sub-acute and chronic stroke yielded excellent reli-
ability with ICC ranging from 0.82 to 0.98 [10, 33–38].
However, one study in sub-acute stroke patients using a
semi-recumbent cycle ergometer showed poor reliability:
there was an increase of 10 % in V'O2peak in the second
test and an ICC for V'O2peak of 0.50 [24]; the reason for
this discrepancy is unclear.
Additional maximal exercise parameters showed
good to excellent test-retest reliability in previous
reports. The ICC of 0.90 for HRpeak in the present
study is comparable to previous reports (0.74 to 0.97)
for a cycle ergometer, a treadmill and a robotics-
Fig. 2 Study flow chart. Reasons for the three exclusions are
detailed in results
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Table 2 Test-retest reliability of the cardiopulmonary performance parameters
TB1 (mean ± SD) TB2 (mean ± SD) p-value MD 95%CI SDD 95 % LoA CoV (%) ICC (95 % CI)
Absolute V'O2peak (mL/min) 1130.5 ± 349.4 1156.4 ± 376.6 0.60 25.8 −77.4, 129.1 200.8 −0.26x̄, 0.26x̄ 11.6 0.85 (0.64, 0.94)
Relative V'O2peak (mL/kg/min) 15.7 ± 4.7 16.0 ± 4.9 0.65 0.3 −1.1, 1.7 2.8 −0.26x̄, 0.26x̄ 11.6 0.84 (0.61, 0.94)
HRpeak (beats/min) 120.9 ± 26.3 124.2 ± 25.2 0.26 3.2 −2.6, 9.0 11.3 −18.9, 25.3 6.9 0.90 (0.76, 0.96)
HRpeak% of APMHR 78.0 ± 15.0 80.1 ± 13.6 0.26 2.04 −1.6, 5.7 7.2 −12.1, 16.2 6.9 0.87 (0.69, 0.95)
RERpeak 1.06 ± 0.09 1.08 ± 0.08 0.10 0.02 −0.01, 0.52 0.06 −0.1, 0.1 4.1 0.78 (0.49, 0.91)
WRpeak (W) 28.0 ± 12.4 29.0 ± 13.3 0.36 1.07 1.4, 3.5 4.6 −7.9, 10.1 13.4 0.94 (0.83, 0.98)
Absolute V'O2VAT (mL/min) (n = 16) 575.4 ± 105.9 635.5 ± 177.3 0.045 60.1 −1.4, 118.9 110.2 −0.34x̄, 0.34x̄ 14.5 0.67 (0.27, 0.87)
Relative V'O2VAT (mL/kg/min) 8.0 ± 1.6 8.8 ± 2.4 0.050 0.8 0.0, 1.6 1.5 −0.34x̄, 0.34x̄ 14.5 0.68 (0.29, 0.88)
V'O2VAT% of V'O2peak (%) 50.3 ± 9.4 53.1 ± 9.1 0.27 2.8 −2.4, 8.2 10 −16.8, 22.4 15.4 0.41 (−0.07, 0.74)
HRVAT (beats/min) (n = 15) 89.5 ± 9.3 91.9 ± 9.7 0.17 2.4 −1.1, 6.0 6.5 −10.3, 15.1 5.5 0.76 (0.44, 0.91)
HRVAT % of HR reserve 32.6 ± 9.2 35.1 ± 11.5 0.33 2.5 −2.8, 7.8 9.5 −16.1, 21.1 19.5 0.58 (0.13, 0.84)
HRVAT % of APMHR 57.3 ± 5.4 58.8 ± 5.2 0.20 1.5 −0.9, 3.8 4.3 −0.62x̄, 0.62x̄ 5.5 0.67 (0.28, 0.87)
Absolute V'O2RCP (mL/min) (n = 12) 956.5 ± 197.9 1002.9 ± 179.4 0.33 46.3 −54.1, 146.6 157.9 −263.2, 355.8 11.6 0.65 (0.17, 0.88)
Relative V'O2RCP (mL/kg/min) 13.4 ± 2.5 14.1 ± 2.5 0.28 0.7 −0.7, 2.1 2.1 −3.4, 4.8 11.6 0.77 (0.24, 0.87)
V'O2RCP% of V'O2peak (%) 77.2 ± 8.8 82.1 ± 6.8 0.035 4.9 0.4, 9.5 7.1 −9.0, 18.8 8.3 0.50 (−0.02, 0.82)
HRRCP (beats/min) (n = 11) 112.5 ± 18.2 113.6 ± 17.7 0.42 1.1 −5.3, 7.4 9.4 −17.3, 19.5 5.8 0.87 (0.59, 0.96)
HRRCP % of HR reserve 70.2 ± 16.2 73.6 ± 10.8 0.48 3.5 −7.0, 14.0 15.6 −27.1, 34.1 18.4 0.37 (−0.28, 0.78)
HRRCP % of APMHR 71.3 ± 12.1 71.9 ± 11.7 0.72 0.7 −3.2, 4.6 5.8 −10.7, 12.1 5.8 0.89 (0.64, 0.97)
RPE dyspnea 5.1 ± 2.0 5.2 ± 2.7 0.93 0.1 −0.8, 0.9 1.7 −3.2, 3.4 28.4 0.76 (0.44, 0.91)
RPE leg effort 6.8 ± 2.1 7.5 ± 1.6 0.23 0.8 −0.3, 1.8 2 −3.1, 4.7 29.5 0.41 (−0.04, 0.73)
V'E/V'O2 at VAT 31.8 ± 4.8 32.8 ± 5.0 0.28 0.9 −0.8, 2.7 3.3 −5.6, 7.4 7.3 0.77 (0.48, 0.91)
V'E/V'CO2 at RCP 33.8 ± 3.7 33.8 ± 3.7 0.91 0.1 −1.2, 1.3 2.0 −3.9, 4.0 4.5 0.87 (0.60, 0.96)
V'E-vs-V'CO2 slope to RCP 32.2 ± 4.8 33.0 ± 5.5 0.36 0.8 −1.0, 2.6 2.8 −4.7, 6.3 6.1 0.85 (0.58,0.96)
6 MWD (n = 12) 502.5 ± 113.4 528.3 ± 113.1 0.010 25.8 7.5, 44.1 28.7 −30.5, 82.1 5.6 0.95 (0.65, 0.99)
n = 17, unless otherwise indicated
TB1 baseline test 1, TB2 baseline test 2, APMHR age-predicted maximal heart rate, VAT ventilatory anaerobic threshold, RCP respiratory compensation point, 6 MWD 6 min-walk distance, MD mean difference, SDD stand-
ard deviation of difference, LoA limits of agreement, CoV coefficient of variation, ICC intraclass correlation coefficient, CI confidence interval, x̄ individual average
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assisted treadmill [10, 24, 33, 35–38]. By way of com-
parison, and bearing in mind the differences in de-
grees of disability and testing devices, the ICCs for
RERpeak and WRpeak of 0.78 and 0.94 found here can
be contrasted with other reports in chronic stroke pa-
tients with mild to moderate disability using a cycle
ergometer and a treadmill (0.72 for RERpeak and 0.99
for work rate) [36, 37].
For the Bland and Altman analysis, we found that
V'O2peak, V'O2VAT and HRVAT as a percentage of HR re-
serve were heteroscedastic (Fig. 3). The finding of het-
eroscedasticity in V'O2peak was also previously reported
in stroke patients and patients with cardiac and pulmon-
ary problems [33, 39, 40]. This means that patients with
low V'O2peak have lower variation in the absolute test-
retest difference compared to patients with higher
V'O2peak. This finding is important as it implies that, for
future studies, it would be necessary to plan the test-
retest reliability protocol for specific levels of exercise
capacity (i.e. V'O2peak) to get the most accurate results
because variations in the test-retest data are not
uniform.
For submaximal exercise thresholds, the reliability of
V'O2VAT and V'O2RCP were lower than for V'O2peak: ICC
was 0.67 and CoV was 14.5 % for V'O2VAT; ICC was 0.65
and CoV was 11.6 % for V'O2RCP. These values, again,
reflect lower reliability compared to healthy individuals
on the same device: the ICC was 0.92 for both V'O2VAT
and V'O2RCP and the CoV was 5.9 and 6.5 % for V'O2VAT
and V'O2RCP, respectively, for healthy individuals [18].
The finding of lower reliability for V'O2VAT and V'O2RCP
compared to V'O2peak was not unexpected as this was
previously documented in healthy individuals, and in pa-
tients with cardiac and pulmonary problems [17, 18, 39].
This was thought to be because of day-to-day biological
variability, which may be related to intrinsic factors such
as daily haemodynamic fluctuations [39]. Additionally,
the lower reliability may be caused by intra and inter-
rater variability in the determination of the submaximal
exercise thresholds. It was found that the intra or inter-
rater variability was 5 to 12 % in patients with congestive
heart failure and in normal subjects [41, 42].
HRVAT and HRRCP were shown to have excellent reliabil-
ity. This suggests that the use of HRVAT and HRRCP to set
the recommended intensity for exercise training could be
implemented in practice. RPE showed the lowest reliability
and repeatability. The findings in the present study sup-
port previous evidence that RPE is not an appropriate in-
dicator of exercise intensity in stroke patients at a high-
intensity exercise level [43]. V'E/V'O2 at VAT, V'E/V'CO2
at RCP, and the V'E-vs-V'CO2 slope showed excellent test-
retest reliability with CoVs comparable to healthy individ-
uals (CoV of 4.5 to 7.3 % in stroke patients vs CoV of 2.5
to 6 % in healthy individuals) [18].
In summary, based on this evidence, reliability and re-
peatability of the main CPET parameters obtained from
the RATT are comparable to previous findings reported
in stroke patients using standard exercise testing devices.
Table 3 Changes in cardiopulmonary fitness during 4 weeks
TB2 TF MD (95 % CI) (TF-TB2) p-value % changes (95 % CI)
Absolute V'O2peak (mL/min) 1156.4 ± 376.6 1170.0 ± 397.5 13.6 (−102.9, 130.2) 0.81 2.8 (−6.3, 11.9)
Relative V'O2peak (mL/kg/min) 16.0 ± 4.9 16.2 ± 5.0 0.2 (−1.3, 1.6) 0.80 2.8 (−6.3, 11.9)
HRpeak (beats/min) 124.2 ± 25.2 124.5 ± 23.5 0.4 (−4.7, 5.4) 0.88 0.9 (−3.1, 5.0)
RERpeak 1.08 ± 0.08 1.08 ± 0.10 0.001 (−0.02, 0.03) 0.89 0.2 (−2.3, 2.6)
WRpeak (W) (n = 16) 29.0 ± 13.3 30.0 ± 14.0 1.0 (−1.8, 3.8) 0.46 2.6 (−7.3, 12.6)
Absolute V'O2VAT (mL/min) (n = 16) 637.4 ± 173.3 569.3 ± 151.3 −68.1 (−107.5, −28.7) 0.002 −9.6 (−15.1, 4.0)
Relative V'O2VAT (mL/kg/min) 8.8 ± 2.3 7.9 ± 2.0 −0.9 (−1.5, −0.4) 0.002 −9.6 (−15.1, 4.0)
HRVAT (beats/min) 93.8 ± 11.5 91.1 ± 7.4 −2.6 (−6.8, 1.5) 0.20 −2.1 (−6.2, 2.0)
Absolute V'O2RCP (mL/min) (n = 11) 1018.7 ± 179.1 1055.4 ± 199.4 36.7 (−80.4, 153.7) 0.50 4.5 (−5.9, 14.9)
Relative V'O2RCP (mL/kg/min) 14.2 ± 2.5 14.7 ± 2.5 0.5 (−1.0, 1.9) 0.48 4.5 (−5.9, 14.9)
HRRCP (beats/min) 118.2 ± 16.8 116.8 ± 19.0 −1.3 (−8.8, 6.1) 0.69 −1.0 (−7.7, 5.7)
RPE dyspnea 5.2 ± 2.7 4.5 ± 1.9 −0.7 (−1.9, 0.5) 0.25 −0.7 (−25.2, 23.8)
RPE leg effort 7.5 ± 1.6 6.1 ± 2.2 −1.4 (−2.8, −0.2) 0.028 −16.4 (−32.4, 0.4)
V'E/V'O2 at VAT (n = 16) 32.4 ± 4.6 32.4 ± 4.2 0.1 (−1.2, 1.3) 0.93 0.5 (−3.2, 4.3)
V'E/V'CO2 at RCP (n = 11) 33.7 ± 3.8 33.5 ± 4.4 −0.1 (−1.7, 1.4) 0.86 −0.4 (−5.2, 4.5)
V'E-vs-V'CO2 slope to RCP (n = 11) 32.8 ± 5.7 32.0 ± 4.6 −0.8 (−3.4, 1.9) 0.53 −1.3 (−8.4, 5.8)
6MWD (n = 12) 528.3 ± 113.1 526.7 ± 114.5 −1.7 (−26.1 to 22.8) 0.89 0.1 (−5.0 to 5.2)
n = 17, unless otherwise indicated
TB2 baseline test 2, TF follow up test, MD mean difference, CI confidence interval
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However, the reliability and repeatability levels found
here in stroke patients were generally lower than for
healthy individuals on the RATT.
Changes in cardiopulmonary fitness after 4 weeks
Apart from V'O2VAT, the main cardiopulmonary per-
formance parameters did not demonstrate any statisti-
cally significant differences over the four week period.
This may be because the follow up time was short and
because more than half of the patients who participated
in this study were in the chronic phase following stroke.
The non-significant change in mean V'O2peak from 16.0
to 16.2 mL/kg/min is comparable to a study in a control
group of chronic stroke patients: 15.1 to 15.2 mL/kg/
min in a 10-week period [37]. This reflects that without
any specific exercise intervention, changes in V'O2peak
are unlikely to be seen over a short period.
There was a significant difference (decrease) in V'O2VAT
over the 4-week period (TB2 vs TF). However, based on
the large and significant difference in V'O2VAT between
tests TB1 and TB2 (mean difference of +60.1 mL/min)
and the fact that V'O2VAT from TB1 was only 575.4 mL/
min (Table 2), this is considered not to be clinically
significant.
The observation of no changes in cardiopulmonary fit-
ness over 4 weeks might serve as a baseline for future
studies which implement a training intervention using
the RATT.
General comments
V'O2peak averaged over the three tests was 16 mL/kg/
min. This is in line with previous reports and shows that
cardiopulmonary fitness in stroke patients is low (8 to
22 mL/kg/min, 26 to 87 % of age and sex-matched pre-
diction) [8].
The cardiopulmonary fitness values obtained in this
study need to be interpreted with caution. The V'O2peak
and V'O2 at submaximal exercise thresholds are device
Fig. 3 Bland-Altman plots for the main outcome measures. The differences between test 2 (TB2) and test 1 (TB1) are plotted against the average
values of TB1 and TB2
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specific: it was found that peak and submaximal V'O2
were approximately 20 % lower on the RATT than the
cycle ergometer in healthy individuals [17, 18]. The HR
response is also device specific: the HRpeak of 80 % of
age predicted maximal heart rate (APMHR) obtained
from CPET on the RATT in this study is at the lower
end of the range for HRpeak reported for a recumbent
cycle ergometer, an upright cycle ergometer and a tread-
mill in chronic ambulatory stroke patients (78.2 to
94.7 % of APMHR) [34, 44, 45]. The lower values for
V'O2peak and HRpeak on the RATT compared to other
devices may be because of more body support provided
and a difference in the movement pattern of exercise on
the RATT [17].
An RERpeak of > 1.0 is a recommended corroboratory
criterion for detection of maximal effort in stroke pa-
tients [46]. This criterion was satisfied here in 82.4 % of
all tests, even though severely disabled patients were in-
cluded. This is considered a high proportion compared
to previous reports of only 17.6 to 62.1 % in patients
with sub-acute or chronic ambulatory stroke tested on a
treadmill [44, 47, 48], 44 % of sub-acute stroke patients
tested on a semi-recumbent cycle ergometer [24], and
78.9 % of sub-acute stroke patients using a cycle ergom-
eter [49]. These differences in the proportion of patients
who achieved the criterion for maximal effort points to
the importance of the device employed for CPET. Pa-
tients may experience difficulty exercising on a treadmill
at higher speeds because of balance problems or fear of
falling and they may have problems with leg control dur-
ing cycling that prevent them from reaching their max-
imal exercise capacity. The RATT, in contrast, provides
a body harness, thigh cuffs and foot plates to secure the
patients, thus enabling them to exercise to a higher in-
tensity safely and securely.
Overall, the VAT was identified in 16/17 (94.1 %)
(TB1), 17/17 (100 %) (TB2) and 16/17 (94.7 %) (TF) pa-
tients. The RCP was identified in 12/17 (70.6 %) (TB1),
14/17 (82.4 %) (TB2) and 13/17 (76.5 %) (TF) patients.
In contrast, the VAT was previously demonstrated to be
identifiable in only 67.3 to 83.5 % of chronic stroke pa-
tients exercising on a semi-recumbent cycle ergometer,
an upright cycle ergometer or a treadmill [45]. To the
best of our knowledge, there are no other studies in
stroke patients that reported identification of an RCP,
which is a point of substantially higher exercise intensity
than the VAT, apart from our own feasibility study [15].
The finding of high proportions of patients who were
able to exercise on the RATT to a sufficiently high level
of intensity to allow identification of both the VAT and
the RCP is regarded as an important finding. These sub-
maximal exercise thresholds provide additional informa-
tion regarding a patient’s fitness status [23, 50] and they
can be used to follow up after an exercise intervention
[51, 52]. Moreover, these submaximal exercise thresholds
could be adopted for the prescription of individualised
exercise programmes because the exercise intensity be-
tween the VAT and RCP reflects the recommended indi-
vidualized moderate to high intensity exercise regime [53].
HRVAT in this study was lower than the value reported
in mild to moderate chronic stroke on a treadmill: here,
HRVAT was approximately 59 % of APMHR and in a
study of Bosch et al. (n = 8) it was 66 % of APMHR [26].
This difference may be due to the device specific re-
sponses to exercise as mentioned above.
Limitations
The strict patient eligibility criteria described in
Methods and the exclusion of patients who had cardiac
problems or who were not approved by the cardiologist
for CPET led to the small sample size in this study,
which may limit generalizability of the findings. Further
investigation in a large cohort of stroke patients from
the principal target population, that is, patients with
severe disability, is warranted.
Conclusions
These findings provide the first evidence of test-retest reli-
ability and repeatability of the principal CPET variables
using the novel RATT system and testing methodology,
together with evidence of high success rates in identifica-
tion of submaximal CPET threshold variables. Good to
excellent test-retest reliability and repeatability were found
for all submaximal and maximal CPET variables. Reliabil-
ity and repeatability of the main CPET parameters in
stroke patients on the RATT were comparable to previous
findings in stroke patients using standard exercise testing
devices. The RATT has potential to be used as an alterna-
tive exercise testing device in patients who have limita-
tions for use of standard exercise testing devices.
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